ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,309Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 247

$409K Total Retail Price of All Prescriptions

Rank: 66 out of 247

413 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 6,277 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 356 327 1 5
HYDROCODONE-ACETAMINOPHEN 272 177 S3 2 11
LISINOPRIL 249 221 3 2
HYDROCHLOROTHIAZIDE 223 209 4 9
SIMVASTATIN 211 178 5 1
AMLODIPINE BESYLATE 204 182 6 6
LEVOTHYROXINE SODIUM 203 180 7 3
PREDNISONE 191 177 8 21
LOVASTATIN 163 138 9 22
WARFARIN SODIUM 159 145 10 13
OMEPRAZOLE 158 148 11 4
ATENOLOL 144 138 12 10
SERTRALINE HCL 137 115 13 16
METFORMIN HCL 130 112 14 12
MIRTAZAPINE 113 109 15 46
METOPROLOL SUCCINATE 107 107 16 14
LOSARTAN POTASSIUM 106 99 17 15
GLYBURIDE 94 80 R 18 41
PROAIR HFA 93 71 19 29
TRAMADOL HCL 86 86 20 25
ALLOPURINOL 79 65 21 33
LANTUS 76 68 22 39
PRAMIPEXOLE DIHYDROCHLORIDE 75 75 23 123
GABAPENTIN 75 59 23 17
FLUOXETINE HCL 71 60 25 49
METOPROLOL TARTRATE 70 70 26 7
PANTOPRAZOLE SODIUM 70 56 26 19
OXYCODONE HCL 68 44 S2 28 27
SPIRONOLACTONE 68 68 28 53
RANITIDINE HCL 65 58 30 34
POTASSIUM CHLORIDE 64 60 31 36
ADVAIR DISKUS 63 54 32 18
TRIAMCINOLONE ACETONIDE 60 55 33 94
ENALAPRIL MALEATE 59 49 34 61
AMITRIPTYLINE HCL 56 41 R 35 55
CYMBALTA 56 39 35 52
JANTOVEN 55 49 37 76
ATORVASTATIN CALCIUM 54 54 38 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.